Does an adult who has received a single dose of Engerix‑B (recombinant hepatitis B vaccine) need additional hepatitis B vaccine doses?

Yes, an Adult Who Has Received One Dose of Engerix-B Requires Two Additional Doses to Complete the Series

An adult who has received a single dose of Engerix-B must continue with two additional doses—the series should never be restarted, regardless of how much time has elapsed since the first dose. 1

Standard Completion Schedule

• The second dose should be administered as soon as possible, with a minimum interval of 4 weeks after the first dose. 1
• The third dose must be given at least 8 weeks after the second dose AND at least 16 weeks (approximately 4 months) after the first dose. 1
• The preferred timing for the third dose is approximately 6 months after the initial dose, following the standard 0-1-6 month schedule. 1, 2

Critical Management Principles

• Never restart the hepatitis B vaccine series after an interruption—simply continue from where the patient left off, regardless of the time interval that has elapsed. 1, 3
• There is no maximum interval between doses; even if years have passed, the series remains valid and should be continued rather than restarted. 1
• Doses administered up to 4 days before the minimum required interval are still considered valid. 1

Why Three Doses Are Essential

• A single dose of hepatitis B vaccine does not produce adequate long-term immunity. Research demonstrates that adults who received only one dose had no detectable antibody protection after 5 years. 4
• The standard 3-dose series of Engerix-B (20 mcg for adults) produces protective antibody levels (≥10 mIU/mL) in >90% of healthy adults under age 40, with a geometric mean titer of 2,204 mIU/mL one month after completion. 1, 2
• Two doses provide better but still incomplete protection: only 61.4% of adults who received two doses maintained protective antibody levels at 5 years. 4

Practical Scheduling Guidance

For an adult who received one dose at an unknown time in the past:

• Administer the second dose immediately at the current visit (no need to wait if the 4-week minimum has already passed). 1
• Schedule the third dose for 8 weeks after the second dose, ensuring it falls at least 16 weeks after the first dose. 1
• If the patient's schedule allows, aim for the third dose at approximately 6 months from the original first dose for optimal immunogenicity. 2

Special Considerations

• Switching vaccine brands is acceptable—if Engerix-B is unavailable, the series can be completed with Recombivax HB or other hepatitis B vaccines without restarting. 1, 2
• Post-vaccination serologic testing is not routinely required for healthy adults, but should be performed 1-2 months after series completion for healthcare workers, public safety personnel, hemodialysis patients, and immunocompromised individuals. 1
• Adults over age 40 may have lower antibody responses (geometric mean titer of 610 mIU/mL versus higher titers in younger adults), but the 3-dose series still provides adequate protection in 88% of this population. 2

Common Pitfalls to Avoid

• Do not restart the series simply because a long interval has passed—this wastes doses and delays protection. 1
• Do not assume one or two doses provide adequate protection—only a complete 3-dose series ensures durable immunity in the majority of adults. 4
• Do not delay the second dose waiting for an "ideal" interval—administer it as soon as the patient presents, as long as the 4-week minimum has been met. 1